Literature DB >> 19427447

Changes in diastolic dysfunction in diabetes mellitus over time.

Aaron M From1, Christopher G Scott, Horng H Chen.   

Abstract

Several studies have demonstrated evidence for preclinical left ventricular (LV) diastolic dysfunction in patients with diabetes mellitus (DM) independent of coronary disease or hypertension. The objectives of our study were to determine if LV diastolic dysfunction determined by tissue Doppler indexes worsens with duration of DM and to quantify severity of dysfunction as a function of DM duration. From 1996 to 2007, all Olmsted County, Minnesota, residents with DM free of heart failure who had a subsequent measurement of diastolic function using tissue Doppler echocardiography were identified. We identified a validated group of 486 patients with incident DM with a subsequent tissue Doppler echocardiographic assessment of diastolic function. There was a significant association between the ratio of early mitral velocity (E) to medial mitral annulus velocity (e') and time from diabetes diagnosis to echocardiogram using simple linear regression; for every 1 year after the onset of diabetes, E/e' increased by 0.23 (95% confidence interval [CI] 0.16 to 0.30, p = 0.007) after adjustment for age, gender, body mass index, previous coronary disease, previous hypertension, and ejection fraction. A duration of diabetes >/=4 years was independently associated with LV diastolic dysfunction (E/e' >15) in multivariable logistic regression modeling after adjustment for age, gender, body mass index, previous coronary disease, previous hypertension, and ejection fraction (odds ratio 1.91, 95% CI 1.19 to 3.07, p = 0.007). There were 48 deaths in the validated cohort (6 cardiac deaths). In multivariable proportional hazard modeling, E/e' ratio was predictive of all-cause mortality after adjustment for age, gender, coronary disease, hypertension, ejection fraction, left atrial volume, and time from DM to echocardiogram (risk ratio 1.11, 95% CI 1.03 to 1.20, p = 0.005). In conclusion, duration of DM of > or =4 years is correlated with significant LV diastolic dysfunction. LV diastolic dysfunction is predictive of all-cause mortality in patients with DM independent of hypertension and coronary disease.

Entities:  

Mesh:

Year:  2009        PMID: 19427447      PMCID: PMC2700297          DOI: 10.1016/j.amjcard.2009.01.358

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

1.  Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study.

Authors:  S R Ommen; R A Nishimura; C P Appleton; F A Miller; J K Oh; M M Redfield; A J Tajik
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

2.  Isolated and preclinical impairment of left ventricular filling in insulin-dependent and non-insulin-dependent diabetic patients.

Authors:  E Astorri; P Fiorina; G A Contini; D Albertini; G Magnati; A Astorri; M Lanfredini
Journal:  Clin Cardiol       Date:  1997-06       Impact factor: 2.882

Review 3.  Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography.

Authors:  Maurizio Galderisi
Journal:  J Am Coll Cardiol       Date:  2006-09-26       Impact factor: 24.094

4.  Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study).

Authors:  M Galderisi; K M Anderson; P W Wilson; D Levy
Journal:  Am J Cardiol       Date:  1991-07-01       Impact factor: 2.778

5.  Impact of diabetes on cardiac structure and function: the strong heart study.

Authors:  R B Devereux; M J Roman; M Paranicas; M J O'Grady; E T Lee; T K Welty; R R Fabsitz; D Robbins; E R Rhoades; B V Howard
Journal:  Circulation       Date:  2000-05-16       Impact factor: 29.690

6.  Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: The Cardiovascular Health Study.

Authors:  M Lee; J M Gardin; J C Lynch; V E Smith; R P Tracy; P J Savage; M Szklo; B J Ward
Journal:  Am Heart J       Date:  1997-01       Impact factor: 4.749

7.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

8.  Coronary endothelial dysfunction and hyperlipidemia are independently associated with diastolic dysfunction in humans.

Authors:  Ahmad A Elesber; Margaret M Redfield; Charanjit S Rihal; Abhiram Prasad; Shahar Lavi; Ryan Lennon; Verghese Mathew; Lilach O Lerman; Amir Lerman
Journal:  Am Heart J       Date:  2007-06       Impact factor: 4.749

Review 9.  Current clinical applications of spectral tissue Doppler echocardiography (E/E' ratio) as a noninvasive surrogate for left ventricular diastolic pressures in the diagnosis of heart failure with preserved left ventricular systolic function.

Authors:  Stephane Arques; Emmanuel Roux; Roger Luccioni
Journal:  Cardiovasc Ultrasound       Date:  2007-03-26       Impact factor: 2.062

Review 10.  Left atrioventricular remodeling in the assessment of the left ventricle diastolic function in patients with heart failure: a review of the currently studied echocardiographic variables.

Authors:  Luiz C Danzmann; Luiz Carlos Bodanese; Ilmar Köhler; Marco R Torres
Journal:  Cardiovasc Ultrasound       Date:  2008-11-16       Impact factor: 2.062

View more
  45 in total

1.  Left ventricular function in children and adolescents with type 1 diabetes mellitus.

Authors:  Eun Ha Kim; Yeo Hyang Kim
Journal:  Korean Circ J       Date:  2010-03-24       Impact factor: 3.243

2.  Making sense of subclinical cardiac alterations in patients with diabetes.

Authors:  Manan Pareek; Michael Hecht Olsen
Journal:  Bosn J Basic Med Sci       Date:  2019-11-08       Impact factor: 3.363

3.  Comparing the influence of 2009 versus 2016 ASE/EACVI diastolic function guidelines on the prevalence and echocardiographic characteristics of preclinical diastolic dysfunction (stage B heart failure) in a Hispanic population with type 2 diabetes mellitus.

Authors:  Siu-Hin Wan; Andrew S Pumerantz; Fanglong Dong; Cesar Ochoa; Horng H Chen
Journal:  J Diabetes Complications       Date:  2019-05-07       Impact factor: 2.852

4.  Study on Diastolic Dysfunction in Newly Diagnosed Type 2 Diabetes Mellitus and its Correlation with Glycosylated Haemoglobin (HbA1C).

Authors:  Abhay Kumar Chaudhary; Girish Kumar Aneja; Shubhra Shukla; Syed Mohd Razi
Journal:  J Clin Diagn Res       Date:  2015-08-01

Review 5.  Echocardiographic feature of diabetic cardiomyopathy: where are we now?

Authors:  Kazuaki Negishi
Journal:  Cardiovasc Diagn Ther       Date:  2018-02

6.  Analysis of ventricular synchrony: A complex puzzle.

Authors:  Guillermo Romero-Farina; Santiago Aguadé-Bruix
Journal:  J Nucl Cardiol       Date:  2018-03-13       Impact factor: 5.952

Review 7.  Is diabetic cardiomyopathy a specific entity?

Authors:  Mitja Letonja; Danijel Petrovič
Journal:  World J Cardiol       Date:  2014-01-26

8.  Association of glucose metabolism with diastolic function along the diabetic continuum.

Authors:  R Stahrenberg; F Edelmann; M Mende; A Kockskämper; H D Düngen; M Scherer; M M Kochen; L Binder; C Herrmann-Lingen; L Schönbrunn; G Gelbrich; G Hasenfuss; B Pieske; R Wachter
Journal:  Diabetologia       Date:  2010-04-13       Impact factor: 10.122

Review 9.  Heart Failure in Type 2 Diabetes Mellitus.

Authors:  Helena C Kenny; E Dale Abel
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

10.  Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders.

Authors:  Wilfried Dinh; Reiner Füth; Werner Nickl; Thomas Krahn; Peter Ellinghaus; Thomas Scheffold; Lars Bansemir; Alexander Bufe; Michael Coll Barroso; Mark Lankisch
Journal:  Cardiovasc Diabetol       Date:  2009-11-12       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.